Table 1 Study and patient characteristics of included studies
References | Country | Design | Study interval | Sample size | Age/years (mean ± SD) | Male, n (%) | Background diseases | Prevalence (%) | Outcomes | Sarcopenia criteria | Diagnostic method |
|---|---|---|---|---|---|---|---|---|---|---|---|
Doolittle et al. [20] | USA | Retrospective cohort study | 2009–2017 | 238 | 60.4 ± 17.4 | 160 (67.2%) | Trauma | 36.9 | MV time, ICU LOS, LOS | LMM | CT |
Moctezuma-Velázquez et al. [35] | Mexico | Retrospective study | 2020.2–2020.5 | 519 | 51 ± 3.17 | 332 (64.0%) | COVID-19 | 22.0 | Mortality, ICU admission | LMM | CT |
Moon et al. [41] | South Korea | Retrospective study | 2016.8–2018.12 | 190 | 78 ± 1.33 | 113 (59.5%) | Sepsis | 50.5 | ICU LOS, ICU and hospital mortality, LOS | LMM | CT |
Han et al. [29] | Korea | Retrospective study | 2015.1–2015.6 | 311 | 67.3 ± 14.9 | 180 (57.9%) | CAP | 28.9 | All-cause in-hospital mortality, LOS, vasopressor use, Ventilator weaning failure | LMM | CT |
Vongchaiudomchoke et al. [30] | Thailand | Prospective, cohort study | 2018.6–2019.12 | 120 | 75.1 ± 7.6 | 62 (51.7%) | Abdominal surgery | 33.3 | MV time, LOS, ADL, 120-day mortality | LMM + LMS | BIVA, HGD |
Xi et al. [34] | China | Retrospective study | 2010.1–2020.4 | 451 | 41.4 ± 15.9 | 373 (82.7%) | Trauma | 24.8 | MV time, ICU LOS, LOS, overall complications, 28-day and 90-day mortality | LMM | CT |
Yuenyongchaiwat et al. [38] | Thailand | Prospective cohort study | 2018 | 160 | 61.1 ± 11.5 | 90 (60.0%) | Heart surgery | 26.9 | MV time, LOS | LMM + LMS | BIA, HGD |
Joyce et al. [37] | Australia | Retrospective observational study | 2018–2019 | 279 | 63.7 ± 16.4 | 163 (58.4%) | Sepsis | 68 | 30-day mortality, ICU-mortality, ICU LOS, LOS | LMM | CT |
Ng et al. [33] | Malaysia | Retrospective observational study | 2016.1–2016.12 | 228 | 54.4 ± 17.8 | 148 (64.9%) | Surgery | 50 | ICU mortality, In-hospital mortality, MV time, ICU sLOS, LOS | LMM | CT |
Woo et al. [31] | Korea | Retrospective cohort study | 2014–2019 | 45 | 66.4 ± 14.5 | 28 (62.2%) | Surgery | 24.4 | MV time, ICU LOS | LMM | CT |
Kou et al. [40] | China | Retrospective cohort study | 2013–2014 | 96 | 73.0 ± 2.97 | 63 (65.6%) | All kinds of surgery | 31.30 | The rate of DTW; ICU mortality | LMM | CT |
Ji et al. [32] | China | Retrospective cohort study | 2012.08.01–2016.07.31 | 236 | 68.75 ± 4.17 | 139 (58.9%) | Surgery | 48.3 | 30-day mortality, ICU LOS, LOS, and hospital costs | LMM | CT |
Akahoshi et al. [39] | Japan | Retrospective observational study | 2012.05–2015.04 | 84 | 49.95 ± 16.3 | 47 (56.0%) | Trauma | 29.7 | 30-day mortality, ICU LOS, LOS | LMM | CT |
Ebbeling et al. [36] | USA | Prospective cohort study | 2005–2010 | 180 | 74 ± 3.17 | 103 (57.0%) | Trauma | 50.0 | In-hospital mortality, MV time, ICU LOS, LOS | LMM | CT |
Sheean et al. [18] | USA | Cross-sectional study | NR | 56 | 58.5 ± 14.6 | 32 (57.1%) | Infection/Sepsis | 58.60 | NR | LMM | CT |
Weijs et al. [19] | Netherlands | Retrospective cohort study | 2003.12–2012-09 | 240 | 59.5 ± 17.8 | 201 (83.7%) | Trauma | 63.0 | ICU, 28-day and hospital mortality; MV time, ICU LOS, LOS | LMM | CT |
Moisey et al. [7] | USA | Retrospective cohort study | 2009–2010 | 149 | 79 ± 2.7 | 85 (57.0%) | Trauma | 71.0 | Ventilator-free days, ICU-free days, and ICU mortality | LMM | CT |